SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $72.1 million in its first quarter.
On a per-share basis, the South Plainfield, New Jersey-based company said it had a loss of $1.29. Losses, adjusted for non-recurring costs, came to 91 cents per share.
The biopharmaceutical company posted revenue of $53.6 million in the period.
PTC Therapeutics shares have increased almost 9% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $37.38, a rise of 23% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT